| Hypoxia and the metabolic phenotype of prostate cancer cells LH Higgins, HG Withers, A Garbens, HD Love, L Magnoni, SW Hayward, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1787 (12), 1433-1443, 2009 | 126 | 2009 |
| VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer Y Zhang, H Shen, HG Withers, N Yang, KE Denson, AL Mussell, ... Scientific Reports 7 (1), 6190, 2017 | 59 | 2017 |
| Inhibition of cellular respiration by doxorubicin Z Tao, HG Withers, HS Penefsky, J Goodisman, AK Souid Chemical research in toxicology 19 (8), 1051-1058, 2006 | 43 | 2006 |
| Phase IIa study of SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma MS Ahluwalia, DA Reardon, AP Abad, WT Curry, ET Wong, SA Figel, ... Journal of Clinical Oncology 41 (7), 1453-1465, 2023 | 40 | 2023 |
| Identification of genes regulating breast cancer dormancy in 3D bone endosteal niche cultures J McGrath, L Panzica, R Ransom, HG Withers, IH Gelman Molecular cancer research 17 (4), 860-869, 2019 | 23 | 2019 |
| MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer M Hagiwara, A Fushimi, A Bhattacharya, N Yamashita, Y Morimoto, M Oya, ... Oncoimmunology 11 (1), 2029298, 2022 | 17 | 2022 |
| MUC1-C dictates PBRM1-mediated chronic induction of interferon signaling, DNA damage resistance, and immunosuppression in triple-negative breast cancer N Yamashita, Y Morimoto, A Fushimi, R Ahmad, A Bhattacharya, ... Molecular Cancer Research 21 (3), 274-289, 2023 | 15 | 2023 |
| Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer A Fushimi, Y Morimoto, S Ishikawa, N Yamashita, A Bhattacharya, ... Molecular Cancer Research 20 (9), 1379-1390, 2022 | 9 | 2022 |
| Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma MJ Ciesielski, MS Ahluwalia, DA Reardon, AP Abad, WT Curry, ET Wong, ... J. Clin. Oncol 40 (2037), 10.1200, 2022 | 3 | 2022 |
| Abstract LB-148: Characterization of an off-target RNAi genomic screen hit identifies GPRC6A as a novel suppressor of metastatic chemotaxis and invasiveness HG Withers, IH Gelman Cancer Research 77 (13_Supplement), LB-148-LB-148, 2017 | 1 | 2017 |
| NK receptors enable TCR-mediated CTL recognition and killing of cancer cells expressing non-mutated tumor-associated antigens B Dong, N Obermajer, T Tsuji, J Matsuzaki, C Bonura, H Withers, M Long, ... Cancer Research 84 (6_Supplement), 3966-3966, 2024 | | 2024 |
| MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells N Yamashita, H Withers, Y Morimoto, A Bhattacharya, N Haratake, ... Iscience 26 (11), 108168, 2023 | | 2023 |
| NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells B Dong, N Obermajer, T Tsuji, J Matsuzaki, C Bonura, H Withers, M Long, ... Research Square, 2023 | | 2023 |
| Molecular characterization of metastatic colorectal cancer (mCRC) in patients (pts) treated with cetuximab and pembrolizumab. C Fountzilas, S Rosario, HG Withers, S Mukherjee, DL Bajor, JN Saltzman, ... Journal of Clinical Oncology 41 (4_suppl), 178-178, 2023 | | 2023 |
| PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA M Ahluwalia, MJ Ciesielski, DA Reardon, A Abad, W Curry, E Wong, ... NEURO-ONCOLOGY 24, 66-66, 2022 | | 2022 |
| The role of HBP1 in controlling breast cancer dormancy reawakening IH Gelman, S Degan, HG Withers, SAK Venkata Cancer Research 82 (12_Supplement), 3643-3643, 2022 | | 2022 |
| Novel AKT isoform-preferred substrates as potentially targetable drivers of metastatic prostate cancer S Degan, R Holtz, HG Withers, J Qu, SS Rasam, IH Gelman Cancer Research 82 (12_Supplement), 154-154, 2022 | | 2022 |
| Functional genomic screens for novel metastasis suppressor genes in breast and prostate cancer models HG Withers State University of New York at Buffalo, 2018 | | 2018 |
| The miR-96/RARγ signaling axis governs androgen signaling and PCa progression MD Long, PK Singh, JR Russell, G Llimos, S Rosario, A Rizvi, H Withers, ... bioRxiv, 198465, 2017 | | 2017 |
| Abstract LB-167: Off-target analysis of RNAi screens identifies microRNA seed sequence contributing to metastatic invasion HG Withers, R Ransom, IH Gelman Cancer Research 76 (14 Supplement), LB-167-LB-167, 2016 | | 2016 |
